FDCDDQ
AMRX icon

Federation des caisses Desjardins du Quebec’s Amneal Pharmaceuticals AMRX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$809 – 2884
2025
Q2 		$809 Hold
100
– – ﹤0.01% 2530
2025
Q1 		$838 Hold
100
– – ﹤0.01% 2437
2024
Q4 		$792 Hold
100
– – ﹤0.01% 2344
2024
Q3 		$832 Buy
+100
New +$782 ﹤0.01% 2339
2019
Q2 		– Sell
-10,830
Closed -$153K – 2261
2019
Q1 		$153K Sell
10,830
-4,460
-29% -$58.9K ﹤0.01% 1049
2018
Q4 		$207K Hold
15,290
– – ﹤0.01% 970
2018
Q3 		$339K Sell
15,290
-658
-4% -$13.8K 0.01% 849
2018
Q2 		$262K Buy
+15,948
New +$280K ﹤0.01% 983

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return